Evidence map›Paper›PMID 39948243›Full record

ArticleNPJ digital medicine2025

Personalized decision making for coronary artery disease treatment using offline reinforcement learning.

Peyman Ghasemi, Matthew Greenberg, Danielle A Southern, Bing Li, James A White, Joon Lee

Abstract read
In one paragraph

Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Peyman GhasemiData Intelligence for Health Lab, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.ORCID http://orcid.org/0000-0002-1890-0715
Matthew GreenbergDepartment of Mathematics and Statistics, Faculty of Science, University of Calgary, Calgary, Alberta, Canada.
Danielle A SouthernCentre for Health Informatics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Bing LiCentre for Health Informatics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
James A WhiteDepartment of Cardiac Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.ORCID http://orcid.org/0000-0002-5297-4507
Joon LeeData Intelligence for Health Lab, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. joon.lee@ucalgary.ca.

Funding

Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) PJT 178027
6 · The paper itself

Abstract

Choosing optimal revascularization strategies for patients with obstructive coronary artery disease (CAD) remains a clinical challenge. While randomized controlled trials offer population-level insights, gaps remain regarding personalized decision-making for individual patients. We applied off-policy reinforcement learning (RL) to a composite data model from 41,328 unique patients with angiography-confirmed obstructive CAD. In an offline setting, we estimated optimal treatment policies and evaluated these policies using weighted importance sampling. Our findings indicate that RL-guided therapy decisions outperformed physician-based decision making, with RL policies achieving up to 32% improvement in expected rewards based on composite major cardiovascular events outcomes. Additionally, we introduced methods to ensure that RL CAD treatment policies remain compatible with locally achievable clinical practice models, presenting an interpretable RL policy with a limited number of states. Overall, this novel RL-based clinical decision support tool, RL4CAD, demonstrates potential to optimize care in patients with obstructive CAD referred for invasive coronary angiography.

Identifiers

PMID39948243
PMCPMC11825836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.